Skip to main content
. 2020 Oct 12;143(4):298–309. doi: 10.1161/CIRCULATIONAHA.120.050391

Figure 1.

Figure 1.

Effect of dapagliflozin on the primary outcome by eGFR at baseline. The blue line represents continuous hazard ratio, and the gray area represents the 95% CI with the overall hazard ratio for the effect of dapagliflozin on the primary outcome given by the dashed red line. eGFR indicates estimated glomerular filtration rate.